
Beclot 500mg/250mg Tablet MR
Marketer
Bipi Lifesciences Pvt Ltd
Salt Composition
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Overview Beclot 500mg/250mg Tablet MR
Tranexamic acid/mefenamic acid 500mg/250mg modified-release tablets are a combined medication indicated for managing heavy menstrual bleeding and associated pain. This treatment stabilizes blood clots, thus reducing excessive menstrual flow. It also inhibits the production of pain and inflammation-inducing chemical mediators. The tablets can be taken with food at any time of day, but consistent daily timing is recommended. For optimal efficacy, initiation should coincide with the first day of menstruation. Continue treatment as directed by your physician. Take the prescribed dose and duration; if a dose is missed, take it as soon as remembered. Complete the full course of treatment, even with symptom improvement. Report to your doctor if menstrual bleeding patterns don't improve after three consecutive cycles. Common side effects include nausea, abdominal pain, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal discomfort. Diarrhea is also possible; increased fluid intake is advisable to mitigate dehydration. Consult your physician if menstrual flow remains unchanged after three consecutive cycles. Prior to commencing treatment, disclose any kidney issues, vaginal bleeding disorders, or current pregnancies/breastfeeding to your doctor. Inform your physician about all other medications being taken. Regular eye examinations may be required during treatment. Alcohol consumption should be avoided while using this medication.
Uses of Beclot 500mg/250mg Tablet MR
Managing excessive menstrual flow and menstrual discomfort.
Major Benefits of Beclot 500mg/250mg Tablet MR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Beclot 500mg/250mg Modified-Release Tablet should be taken with a meal.
Common Side effects of Beclot 500mg/250mg Tablet MR:
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
- Nasal congestion (stuffy nose)
- Headache
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
- Stomach pain
- Sinus pain
- Sinus inflammation
How to use Beclot 500mg/250mg Tablet MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/250mg Beclot MR tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.
How Beclot 500mg/250mg Tablet MR works:
Beclot 500mg/250mg MR tablets contain Tranexamic Acid and Mefenamic Acid, working synergistically to manage heavy menstrual bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thus reducing excessive bleeding. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, alleviating associated pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Beclot 500mg/250mg MR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Beclot 500mg/250mg MR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential dangers before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The extended-release Beclot 500mg/250mg tablet is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Taking Beclot 500mg/250mg MR tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Beclot 500mg/250mg MR tablets cautiously, as dosage modification may be necessary. Consult a physician before use. Beclot 500mg/250mg MR tablets are contraindicated in those with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Beclot 500mg/250mg MR tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Beclot 500mg/250mg Tablet MR :
Should you forget a Beclot 500mg/250mg MR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Beclot 500mg/250mg Tablet MR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Hematological |
